Related Experiment Video
Updated: Jun 29, 2026

07:08
Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Structural Retinal and Choroidal Changes in Toxoplasmic Retinochoroiditis Assessed by Swept-Source Optical Coherence
Ramavath Sree Keerti1, Manjit Boro1, Muhsin Hashim1
1Department of Vitreoretinal Services, Sankara Nethralaya, Chennai, India.
Ocular Immunology and Inflammation
|May 7, 2026
Summary
Swept-source optical coherence tomography (SS-OCT) identifies unique retinal and choroidal changes in active, reactive, and inactive toxoplasma retinochoroiditis (TRC). These SS-OCT biomarkers aid in staging disease activity, guiding treatment, and monitoring patient prognoses.
Area of Science:
- Ophthalmology
- Medical Imaging
- Infectious Diseases
Background:
- Toxoplasma retinochoroiditis (TRC) presents with varied clinical activity.
- Accurate staging is crucial for effective management and monitoring of TRC.
- Swept-source optical coherence tomography (SS-OCT) offers high-resolution cross-sectional imaging of the retina and choroid.
Purpose of the Study:
- To characterize distinct retinal and choroidal structural changes in active, reactive, and inactive phases of TRC using SS-OCT.
- To establish stage-specific imaging biomarkers for TRC.
- To evaluate the utility of SS-OCT in therapeutic decision-making and disease monitoring.
Main Methods:
- A retrospective study analyzed 33 patients (39 eyes) with TRC, categorized into active, reactive, or inactive phases.
- SS-OCT was employed to measure central foveal thickness (CFT), subfoveal choroidal thickness (SFCT), retinal layers, and vitreous characteristics.
- Statistical analyses included Kruskal-Wallis H test and multivariate logistic regression; interobserver reproducibility was assessed using intraclass correlation coefficients (ICC).
Main Results:
- Active TRC eyes exhibited significant retinal edema (CFT) and choroidal thickening (SFCT), along with vitreous abnormalities and fluid.
- Reactive phases showed intermediate changes with retinal pigment epithelium (RPE) hyperreflectivity and outer retinal atrophy.
- Inactive TRC eyes demonstrated retinal thinning, ellipsoid zone disruption, RPE loss, and epiretinal membranes; CFT and SFCT were significantly different across phases (p<0.01).
Conclusions:
- SS-OCT reveals distinct structural signatures correlating with TRC disease activity phases.
- These findings validate SS-OCT for quantifiable disease staging, treatment monitoring, and prognostication in TRC.
- Further multimodal imaging studies are warranted to complement SS-OCT findings.

